Seer Inc (SEER)
2.42
+0.10
(+4.40%)
USD |
NASDAQ |
Nov 14, 16:00
2.42
0.00 (0.00%)
After-Hours: 20:00
Seer Enterprise Value: -110.92M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -110.92M |
| November 12, 2024 | -114.34M |
| November 11, 2024 | -115.51M |
| November 08, 2024 | -107.26M |
| November 07, 2024 | -116.69M |
| November 06, 2024 | -125.54M |
| November 05, 2024 | -127.90M |
| November 04, 2024 | -128.49M |
| November 01, 2024 | -134.39M |
| October 31, 2024 | -134.39M |
| October 30, 2024 | -129.62M |
| October 29, 2024 | -129.62M |
| October 28, 2024 | -132.01M |
| October 25, 2024 | -136.18M |
| October 24, 2024 | -137.37M |
| October 23, 2024 | -137.96M |
| October 22, 2024 | -136.77M |
| October 21, 2024 | -133.79M |
| October 18, 2024 | -132.60M |
| October 17, 2024 | -132.01M |
| October 16, 2024 | -129.62M |
| October 15, 2024 | -130.22M |
| October 14, 2024 | -129.03M |
| October 11, 2024 | -129.62M |
| October 10, 2024 | -133.20M |
| Date | Value |
|---|---|
| October 09, 2024 | -129.62M |
| October 08, 2024 | -132.01M |
| October 07, 2024 | -132.01M |
| October 04, 2024 | -128.43M |
| October 03, 2024 | -132.01M |
| October 02, 2024 | -134.39M |
| October 01, 2024 | -132.01M |
| September 30, 2024 | -130.22M |
| September 27, 2024 | -163.36M |
| September 26, 2024 | -173.80M |
| September 25, 2024 | -178.41M |
| September 24, 2024 | -176.57M |
| September 23, 2024 | -175.95M |
| September 20, 2024 | -177.79M |
| September 19, 2024 | -175.34M |
| September 18, 2024 | -174.72M |
| September 17, 2024 | -177.79M |
| September 16, 2024 | -180.25M |
| September 13, 2024 | -179.64M |
| September 12, 2024 | -182.71M |
| September 11, 2024 | -184.55M |
| September 10, 2024 | -185.78M |
| September 09, 2024 | -183.94M |
| September 06, 2024 | -182.71M |
| September 05, 2024 | -182.71M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-237.42M
Minimum
Nov 16 2023
4.694B
Maximum
Dec 10 2020
539.33M
Average
-10.15M
Median
Aug 01 2023
Enterprise Value Benchmarks
| Organogenesis Holdings Inc | 560.89M |
| Poseida Therapeutics Inc | 138.61M |
| CEL-SCI Corp | 38.36M |
| AIM ImmunoTech Inc | 7.900M |
| IGC Pharma Inc | 26.09M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.33M |
| Revenue (Quarterly) | 3.942M |
| Total Expenses (Quarterly) | 28.27M |
| EPS Diluted (Quarterly) | -0.35 |
| Gross Profit Margin (Quarterly) | 46.88% |
| Profit Margin (Quarterly) | -541.0% |
| Earnings Yield | -53.72% |
| Normalized Earnings Yield | -53.72 |